Angiodynamics Inc. (ANGO) stock forecast and price target
Price $11.87 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($11.87)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends May 31, 2027 | $-0.28 | −86.7% | $338M |
| Next fiscal year ends May 31, 2028 | $-0.11 | +59.5% | $355M |
| Next quarter ends November 30, 2026 | $-0.07 | +0.0% | $84M |
| Quarter after ends February 28, 2027 | $-0.09 | −550.0% | $83M |
Consensus of the analysts covering Angiodynamics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Our model vs. Wall Street
Analysts see 66.4% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Angiodynamics’s intrinsic value about 77% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Angiodynamics stock price target?
The average 12-month target from 4 analysts is $19.75, 66.4% above the current price of $11.87 Targets range from $17.00 to $24.00.
Is Angiodynamics a buy according to analysts?
The consensus rating is “None” (4 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Angiodynamics expected to earn?
Analysts expect EPS of $-0.28 for the fiscal year ending May 31, 2027 and $-0.11 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.